N-[4-[2-(Propylamino)Ethyl]Phenyl]-4-(Trifluoromethoxy)Benzenesulfonamide Hydrochloride N-[4-[2-(丙基氨基)乙基)苯基] -4-(三氟甲氧基)-苯磺酰胺盐酸盐

CAS 1783978-03-9 MFCD883978039

化学结构图

1783978-03-9
SMILES:

别名和识别编码

Chemical NameN-[4-[2-(Propylamino)Ethyl]Phenyl]-4-(Trifluoromethoxy)Benzenesulfonamide Hydrochloride
Chemical Name TranslationN-[4-[2-(丙基氨基)乙基)苯基] -4-(三氟甲氧基)-苯磺酰胺盐酸盐
信息真实价格透明    资金保障    专业采购外包团队在线服务   
信息真实价格透明    资金保障    专业采购外包团队在线服务   
品牌质保精细包装    现货库存    一流品牌服务   

相关文献及参考

  • [2]. Vonderfecht SL, et al. Myopathy related to administration of a cationic amphiphilic drug and the use of multidose drug distribution analysis to predict its occurrence. Toxicol Pathol. 2004 May-Jun;32(3):318-25.
  • [1]. Rudmann DG, et al. Epididymal and systemic phospholipidosis in rats and dogs treated with the dopamine D3 selective antagonist PNU-177864. Toxicol Pathol. 2004 May-Jun;32(3):326-32.
  • [1]. Rudmann DG, et al. Epididymal and systemic phospholipidosis in rats and dogs treated with the dopamine D3 selective antagonist PNU-177864. Toxicol Pathol. 2004 May-Jun;32(3):326-32.
  • [2]. Vonderfecht SL, et al. Myopathy related to administration of a cationic amphiphilic drug and the use of multidose drug distribution analysis to predict its occurrence. Toxicol Pathol. 2004 May-Jun;32(3):318-25.

系列性分类

  1. Medical Research Areas
  2. GPCR & G Protein
  3. Dopamine Receptor  (多巴胺受体)

相关产品推荐